James T. Borello RIA’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
GA
James T. Borello RIA's NVO Position: Q3 2026 in Review
James T. Borello RIA reduced its Novo Nordisk (NVO) stake by 9.2% in Q3 2026, selling an estimated $6.92K and leaving 1,484 shares worth $56.3K. The position accounts for 0.01% of the portfolio, ranked #225.
James T. Borello RIA first reported a position in NVO in Q4 2025 and has held it in 4 quarters since. The position peaked at $78.3K in Q2 2026. 318 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- James T. Borello RIA held 1,484 shares of Novo Nordisk worth $56.3K as of Q3 2026.
- James T. Borello RIA sold 150 Novo Nordisk shares in Q3 2026, an estimated $6.92K.
- Novo Nordisk made up 0.01% of James T. Borello RIA's portfolio in Q3 2026, its #225 holding.
- James T. Borello RIA first reported a position in Novo Nordisk in Q4 2025 and has held it in 4 quarters since.
- James T. Borello RIA's Novo Nordisk position peaked at $78.3K in Q2 2026.
- 318 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.